scispace - formally typeset
C

Carol E. Golin

Researcher at University of North Carolina at Chapel Hill

Publications -  242
Citations -  9917

Carol E. Golin is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Psychological intervention & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 46, co-authored 231 publications receiving 8905 citations.

Papers
More filters
Journal ArticleDOI

A comparison study of multiple measures of adherence to HIV protease inhibitors.

TL;DR: Using HIV viral load as a clinical criterion, methods of measuring adherence to antiretroviral therapy among HIV-infected patients were compared, a composite adherence score (CAS) was developed, and the associations between each adherence measure and viral load were analyzed.
Journal ArticleDOI

Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review

TL;DR: Evidence is limited on whether these approaches are broadly applicable or affect longterm medication adherence and health outcomes and clinical and methodological heterogeneity hindered quantitative data pooling.
Journal ArticleDOI

A prospective study of predictors of adherence to combination antiretroviral medication.

TL;DR: Nearly all patients’ adherence levels were suboptimal, demonstrating the critical need for programs to assist patients with medication taking and the need to assess and treat substance abuse and incorporate adherence aids.
Journal Article

Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States

TL;DR: In this paper, the authors examined the comparative effectiveness of patient, provider, systems, and policy interventions to improve medication adherence for chronic conditions and found evidence that reduced out-of-control medication usage.
Journal ArticleDOI

Medication Therapy Management Interventions in Outpatient Settings A Systematic Review and Meta-analysis

TL;DR: The evidence was insufficient to determine the effect of MTM interventions on most evaluated outcomes and the interventions improved a few measures of medication-related problems and health care use and costs (low strength of evidence) when compared with usual care.